COMBIPHAR
Rizqi Amalia is currently serving as a Finance Budget Control Analyst at COMBIPHAR since August 2022. Prior to this, they worked as a SAP CO Staff at Pou Chen Group Indonesia in February 2020. They also had internships at Otoritas Jasa Keuangan in August 2019 and Central Bank of Indonesia in July 2019. Rizqi previously worked as an Assistant Lecturer for Intermediate Accounting at Universitas Islam Indonesia from August 2018 to January 2019. They recently completed their Master of Accounting degree at Universitas Gadjah Mada in December 2022, following their Bachelor's degree in Accounting from Universitas Islam Indonesia in May 2019.
This person is not in the org chart
This person is not in any teams
COMBIPHAR
1 followers
Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.